GSK-3 Inhibitors: Anti-Diabetic Treatment Associated With Cardiac Risk?

Cardiovascular Drugs and Therapy - Netherlands
doi 10.1007/s10557-016-6669-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

GSK-3 Inhibitors Enhance TRAIL-mediated Apoptosis in Human Gastric Adenocarcinoma Cells

PLoS ONE
Multidisciplinary
2018English

Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

P028 Treatment of BAFF Transgenic Mice With ANTI-TNF: Monoclonal ANTI-TNF Are Associated With a Higher Risk of Lymphoma Than Etanercept

2018English

OP0307 Treatment of Baff Transgenic Mice With ANTI-TNF: Monoclonal ANTI-TNF Are Associated With a Higher Risk of Lymphoma Than Etanercept

2017English

Distinct Roles of GSK-3 and GSK-3 Phosphorylation in the Heart Under Pressure Overload

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Infectious Complications Associated With the Use of Immune Checkpoint Inhibitors in Oncology: Reactivation of Tuberculosis After Anti PD-1 Treatment

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Three Ileus Cases Associated With the Use of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Factors Associated With Adherence to Anti-Hypertensive Treatment in Pakistan

PLoS ONE
Multidisciplinary
2007English

Pioglitazone: An Anti-Diabetic Compound With Anti-Aging Properties

Biogerontology
AgingGerontologyGeriatrics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy